A Patient with Pulmonary Lymphangitic Carcinomatosis Successfully Treated with TS-1 and Cisplatin

DOI Web Site 14 References
  • Kikuchi Norihiro
    Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba
  • Shiozawa Toshihiro
    Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba
  • Ishii Yukio
    Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba
  • Satoh Hiroaki
    Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba
  • Noguchi Masayuki
    Department of Pathology, Institute Basic Medical Sciences, University of Tsukuba
  • Ohtsuka Morio
    Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba

Search this article

Abstract

A 37-year-old man was referred to our hospital with complaints of dyspnea and general fatigue. Chest radiograph and CT scan revealed thickness of bronchovascular bundles in both lungs. In spite of various examinations, the primary lesion was not identified. He received chemotherapy containing TS-1 and cisplatin. Pulmonary lymphangitic carcinomatosis disappeared and the patient achieved a good partial response. He survived for 14 months after the chemotherapy. We believe the combination of TS-1 and cisplatin is one of the attractive options for patients with cancer of unknown primary site.<br>

Journal

  • Internal Medicine

    Internal Medicine 46 (8), 491-494, 2007

    The Japanese Society of Internal Medicine

References(14)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top